Activators of SPANX-C function through a multitude of signaling cascades that converge on the modulation of the protein's phosphorylation state, thereby influencing its activity. Certain small molecules can elevate intracellular cAMP levels, which, in turn, activate protein kinase A (PKA). This kinase is then responsible for the phosphorylation and consequent activation of SPANX-C. Similarly, the activation of protein kinase C (PKC) by other compounds can also result in the phosphorylation of SPANX-C, enhancing its functional activity. Additionally, agents that increase intracellular calcium levels trigger a cascade that activates calmodulin and the calcium/calmodulin-dependent protein kinases (CaMKs). These kinases have the potential to phosphorylate SPANX-C, thus promoting its activation. The use of calcium ionophores also follows a similar route, raising intracellular calcium levels and potentially activating SPANX-C through kinase-mediated phosphorylation.
Other compounds act as modulators of intracellular secondary messenger pathways, indirectly leading to the activation of SPANX-C. For example, inhibitors of phosphodiesterases prevent the degradation of cAMP, leading to sustained PKA activation, which may phosphorylate and hence activate SPANX-C. Certain sphingosine-1-phosphate receptor modulators can activate a range of kinases, which may also result in SPANX-C phosphorylation and activation. Moreover, cAMP analogs are employed to directly stimulate PKA, suggesting another route by which SPANX-C may be activated through phosphorylation. Polyphenols alter kinase signaling pathways, possibly affecting the phosphorylation state of SPANX-C. Finally, the activation of specific transient receptor potential cation channels by certain compounds leads to calcium influx and subsequent activation of kinases that could phosphorylate and activate SPANX-C.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates intracellular cAMP levels by activating adenylate cyclase. Increased cAMP enhances protein kinase A (PKA) activity, which can phosphorylate SPANX-C, leading to its activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which can lead to the phosphorylation of various proteins including SPANX-C, potentially increasing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels, which activates calmodulin and the calcium/calmodulin-dependent protein kinases (CaMKs), possibly leading to the activation of SPANX-C through phosphorylation. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that activates PKA. PKA can then phosphorylate SPANX-C, promoting its activation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A beta-adrenergic agonist that increases cAMP levels in cells, leading to PKA activation which may enhance SPANX-C activity through phosphorylation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-selective inhibitor of phosphodiesterases, leading to an increase in cAMP levels, which activates PKA, potentially resulting in SPANX-C activation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore that raises intracellular calcium levels, which may activate pathways including CaMKs that could phosphorylate and activate SPANX-C. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
A sphingosine-1-phosphate receptor modulator that can lead to the activation of diverse kinases, potentially influencing the phosphorylation state of SPANX-C. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
A selective inhibitor of phosphodiesterase 4, which increases cAMP levels thereby activating PKA that may lead to the activation of SPANX-C. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that activates PKA, which in turn may phosphorylate and activate SPANX-C. | ||||||